Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Persistence of Twinrix in Healthy Adults
NCT00289718Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 2004
- Primary completion
- Mar 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of hepatitis b vaccine recombinant in hepatitis A (HAV), hepatitis B (HBV), sponsored by GSK. Started Nov 2004; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00289718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289718.